VC
REGN icon

Veracity Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Veracity Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46M Buy
5,556
+3
+0.1% +$2.04K 0.94% 16
2026
Q1 		$4.29M Sell
5,553
-73
-1% -$55.9K 1.53% 9
2025
Q4 		$4.34M Buy
5,626
+4
+0.1% +$2.72K 1.28% 11
2025
Q3 		$3.16M Buy
5,622
+25
+0.4% +$14.1K 1.01% 10
2025
Q2 		$2.94M Sell
5,597
-4
-0.1% -$2.23K 1.01% 11
2025
Q1 		$3.55M Sell
5,601
-13
-0.2% -$8.94K 1.38% 8
2024
Q4 		$4M Sell
5,614
-58
-1% -$48.7K 1.44% 9
2024
Q3 		$5.96M Sell
5,672
-140
-2% -$156K 2.26% 7
2024
Q2 		$6.11M Sell
5,812
-310
-5% -$301K 2.54% 6
2024
Q1 		$5.89M Sell
6,122
-241
-4% -$229K 2.29% 7
2023
Q4 		$5.59M Sell
6,363
-104
-2% -$85.6K 2.24% 7
2023
Q3 		$5.32M Sell
6,467
-51
-0.8% -$40.1K 2.47% 5
2023
Q2 		$4.68M Buy
6,518
+17
+0.3% +$13.1K 1.99% 7
2023
Q1 		$5.34M Sell
6,501
-293
-4% -$221K 2.47% 7
2022
Q4 		$4.9M Sell
6,794
-145
-2% -$107K 2.35% 5
2022
Q3 		$4.78M Buy
6,939
+2
+0% +$1.26K 2.6% 6
2022
Q2 		$4.1M Sell
6,937
-110
-2% -$71.5K 2.18% 7
2022
Q1 		$4.92M Sell
7,047
-221
-3% -$140K 2.04% 7
2021
Q4 		$4.59M Buy
7,268
+37
+0.5% +$22.7K 1.84% 10
2021
Q3 		$4.38M Sell
7,231
-530
-7% -$329K 1.88% 8
2021
Q2 		$4.33M Sell
7,761
-8,009
-51% -$4.06M 1.01% 19
2021
Q1 		$7.46M Sell
15,770
-1,406
-8% -$685K 1.59% 10
2020
Q4 		$8.3M Buy
17,176
+792
+5% +$428K 2.08% 7
2020
Q3 		$9.17M Buy
16,384
+322
+2% +$195K 2.5% 4
2020
Q2 		$10M Sell
16,062
-174
-1% -$98.8K 2.8% 6
2020
Q1 		$7.93M Sell
16,236
-1,086
-6% -$448K 2.29% 12
2019
Q4 		$6.5M Buy
+17,322
New +$5.83M 1.68% 11

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Veracity Capital's REGN Position: Q2 2026 in Review

Veracity Capital increased its Regeneron Pharmaceuticals (REGN) stake by 0.05% in Q2 2026, buying an estimated $2.04K and bringing the position to 5,556 shares worth $3.46M. The position accounts for 0.94% of the portfolio, ranked #16.

Veracity Capital first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $10M in Q2 2020. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Veracity Capital held 5,556 shares of Regeneron Pharmaceuticals worth $3.46M as of Q2 2026.
  • Veracity Capital bought 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up 0.94% of Veracity Capital's portfolio in Q2 2026, its #16 holding.
  • Veracity Capital first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Veracity Capital's Regeneron Pharmaceuticals position peaked at $10M in Q2 2020.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.